Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone in IBS-C
NCT00399542Phase 3Completed
- Sponsor
- Sucampo
- Start
- May 2005
- Primary completion
- Jul 2006
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Lubiprostone with Placebo (2 arms). Primary endpoint: Overall Responder Status at 12 weeks. Started May 2005; status: completed.
02
Drugs
cobiprostone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00399542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399542.